Induction of apoptosis of non-small cell lung cancer by a methylated oligonucleotide targeting survivin gene

Cancer Gene Therapy

Volumn 17, Issue 6, 2010, Pages 441-446

  Li, H L ^a   Ma, A N ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cytosine guanine island; Gene therapy; Methylated oligonucleotide; Survivin

Indexed keywords

MESSENGER RNA; OLIGONUCLEOTIDE; SURVIVIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DRUG MECHANISM; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; AZACITIDINE; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA MODIFICATION METHYLASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICROTUBULE-ASSOCIATED PROTEINS; OLIGONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 77952550875     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2009.82     Document Type: Article

References (32)

1. Cohen V, Khuri FR. Chemoprevention of lung cancer: current status and future prospects. Cancer Metastasis Rev 2002; 21: 349-362.
2. Ginsberg RJ, Goldberg M, Waters PF. Surgery in non-small cell lung cancer. In: Roth JA RJ, Weisenburger TH (eds). Thoracic Oncology. 2nd edition. W.B. Saunders Company: Philadelphia, PA, 1995: 124-126.
3. Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3: 46-54.
4. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
5. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998; 152: 43-49.
6. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998; 58: 5315-5320.
7. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584.
8. Salvesen GS, Duckett CS. Apoptosis: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002; 3: 401-410.
9. Wang JX, Zheng S. Caspase-3 and survivin expression in pediatric neuroblastoma and their roles in apoptosis. Chin Med J 2004; 117: 1821-1824.
10. Ulukus EC, Kargi HA, Sis B, Lebe B, Oztop I, Akkoclu A et al. Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis. Appl Immunohistochem Mol Morphol 2007; 15: 31-37.
11. Atikcan S, Unsal E, Demirag F, Koksal D, Yilmaz A. Correlation between survivin expression and prognosis in non-small cell lung cancer. Respir Med 2006; 100: 2220-2226.
12. Karczmarek-Borowska B, Filip A, Wojcierowski J, Smolen A, Pilecka I, Jablonka A. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study. Folia Histochem Cytobiol 2005; 43: 237-242.
13. Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Frever AS et al. Nuclear survivin predicts recurrence and poor survival in patients with resected non-small cell lung carcinoma. Cancer 2005; 103: 1685-1692.
14. Kren L, Brazdil J, Hermanova M, Goncharuk VN, Kallakury BV, Kaur P et al. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases. Appl Immunohistochem Mol Morphol 2004; 12: 44-49.
15. Falleni M, Pellegrini C, Marchetti A, Oprandi B, Buttitta F, Barassi F et al. Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 2003; 200: 620-626.
16. Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA et al. A novel antisense oligonucleotides targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 2000; 60: 2805-2809.
17. Xiang R, Mizutani N, Luo Y, Chiodoni C, Zhou H, Mizutani M et al. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res 2005; 65: 553-561.
18. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402.
19. Jones PA, Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293: 1068-1070.
20. Yao XM, Hu JF, Daniels M, Shiran H, Zhou XJ, Yien HF et al. A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma. J Clin Invest 2003; 111: 265-273.
21. Grossman D, Kim PJ, Schechner JS, Altieri DC. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc Natl Acad Sci USA 2001; 98: 635-640.
22. Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. J Natl Cancer Inst 2001; 93: 1541-1552.
23. Paduano F, Villa R, Pennati M, Folini M, Binda M, Daidone MG et al. Silencing of survivin gene by small interfering RNAs produces supra-additive growth suppression in combination with 17-allylamino-17-demethoxygelda-namycin in human prostate cancer cells. Mol Cancer Ther 2006; 5: 179-186.
24. Blanc-Brude OP, Mehdi Mesri, Wall NR, Plescia J, Dohi T, Altieri DC. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clinical Cancer Research 2003; 9: 2683-2692.
25. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J et al. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1999; 1: 461-466.
26. Mesri M, Wall NR, Li J, Kim RW, Altieri DC. Cancer gene therapy using a survivin mutant adenovirus. J Clin Invest 2001; 108: 981-990.
27. Pennati M, Colella G, Follini M, Citti L, Daidone MG, Zaffaroni N. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis. J Clin Invest 2002; 109: 285-286.
28. Du ZX, Zhang HY, Gao DX, Wang HQ, Li YJ, Liu GL. Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells. Exp Mol Med 2006; 38: 230-240.
29. Guan HT, Xue XH, Dai ZJ, Wang XJ, Li A, Qin ZY. Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol 2006; 12: 2901-2907.
30. Ishii T, Fujishiro M, Masuda M, Teramoto S, Matsuse T. A methylated oligonucleotide induced methylation of GSTP1 promoter and suppressed its expression in A549 lung adenocarcinoma cells. Cancer Lett 2004; 212: 211-223.
31. Shin S, Sung BJ, Cho YS, Kim HJ, Na NC, Hwang JI et al. An antiapoptotic protein human survivin is a direct inhibitor of caspase-3 and-7. Biochemistry 2001; 40: 1117-1123.
32. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33-42.